Pharmac’s current proposal would fund only the Comirnaty vaccine, with alternative brands available solely through its Exceptional Circumstances framework. ACA believes this creates an exclusionary ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

US growth likely to slow to 1.6% this year, hobbled by Trump's trade wars, OECD says. U.S. economic growth will slow to 1.6% this year from 2.8% last year as President ...

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...

Mount Etna has again captivated the world with a spectacular show.

Authorities investigate after 8 injured in Colorado attack by man they say yelled 'Free Palestine' ...

Trump orders Walmart to ‘eat the tariffs’ and stop blaming his trade war for rising prices: ‘I’ll be watching’ Tourist Regret: Where People Wish They Hadn’t Gone in 2025 FDA approves Novavax COVID-19 ...

Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...